NUVL logo

Nuvalent, Inc. (NUVL)

Profile

Full Name

Nuvalent, Inc.

Ticker

NASDAQ: NUVL

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 29, 2021

Indexes

Not included

Website

https://www.nuvalent.com

Employees

162

Key Details

Price

$79.42(+1.39%)

Market cap

$5.73B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

$0.00(0.00% YoY)

PE ratio

-

Next earnings date

Nov 10, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $79.42
    NUVL price is $79.42

    30-Day Relative Volume

    0.64
    NUVL 30-day relative volume is 0.64

    Price Performance

    Price Today change

    +1.39%
    NUVL price is up +1.39% today

    Price YTD change

    +1.46%
    NUVL price is up +1.46% since January 1st

    Price 1-year change

    -24.18%
    NUVL price is down -24.18% year-on-year

    Price 3-year change

    +349.21%
    NUVL price is up +349.21% over the past 3 years

    Price Range

    Price All-time high

    $113.51
    NUVL price is currently -30.03% below its historical high of $113.51

    Price 3-year low

    $15.56
    NUVL price is currently +410.25% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $5.73B
    NUVL market capitalization is $5.73 billion

    Market cap 3-year change

    +569.04%
    NUVL market capitalization is up +569.04% over the past 3 years

    Market cap All-time high

    $7.62B
    NUVL market capitalization is currently -24.84% below its historical high of $7.62 billion

    Market cap sector rank

    89.01%
    NUVL market capitalization is higher than 89.01% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +11.28%
    NUVL shares outstanding is up +11.28% year-on-year

    Shares Outstanding 3-Year Change

    +48.94%
    NUVL shares outstanding is up +48.94% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.04
    NUVL beta is 1.04

    200-day SMA

    $78.05
    NUVL price is currently +1.76% above its 200-day simple moving average

    50-day SMA

    $78.74
    NUVL price is currently +0.86% above its 50-day simple moving average

    RSI

    50.29
    NUVL 14-day relative strength index is 50.29

    Volume

    0.64
    NUVL 30-day relative volume is 0.64

    ATR

    $2.99
    NUVL average true range is $2.99

    10-day Historical Volatility

    36.66%
    NUVL 10-day historical volatility is 36.66%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    NUVL annual revenue is $0.00

    Revenue Analysts estimate

    -
    NUVL annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    NUVL annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.79%
    NUVL annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    $0.00
    NUVL annual earnings per share is $0.00

    EPS Analysts estimate

    -$5.09
    NUVL annual earnings per share is currently -100.00% lower than the consensus analysts' forecast

    EPS 1-year change

    0%
    NUVL annual earnings per share has remained unchanged year-on-year

    EPS Sector rank

    82.45%
    NUVL annual earnings per share is higher than 82.45% of companies in Healthcare sector

    Profit

    Gross profit

    $0.00
    NUVL annual gross profit is $0.00

    Gross margin

    -
    NUVL annual gross profit margin value is unknown

    Operating profit

    -$280.37M
    NUVL annual operating income is -$280.37 million

    Operating margin

    -
    NUVL annual operating profit margin value is unknown

    Net income

    -$260.76M
    NUVL annual net profit is -$260.76 million

    Net margin

    -
    NUVL annual net profit margin value is unknown

    Expenses

    Total expenses

    $280.37M
    NUVL annual total expenses is $280.37 million

    Operating expenses

    $280.37M
    NUVL annual total operating expenses is $280.37 million

    Cost of goods sold

    $0.00
    NUVL annual cost of goods sold is $0.00

    Selling, general & administrative expenses

    $62.59M
    NUVL annual SGA is $62.59 million

    Depreciation and amortization

    -
    NUVL annual depreciation & amortization value is unknown

    Interest expense

    $0.00
    NUVL annual interest expense is $0.00

    Income tax

    $764.00K
    NUVL annual income tax is $764.00 thousand

    EBIT & EBITDA

    EBIT

    -$280.37M
    NUVL annual earnings before interest & taxes is -$280.37 million

    EBITDA

    -$280.37M
    NUVL annual EBITDA is -$280.37 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.14B
    NUVL annual total assets is $1.14 billion

    Non current assets

    $9.30M
    NUVL annual long term assets is $9.30 million

    Current assets

    $1.13B
    NUVL annual total current assets is $1.13 billion

    Cash and cash equivalents

    $145.69M
    NUVL annual cash & cash equivalents is $145.69 million

    Accounts receivable

    -
    NUVL annual accounts receivable value is unknown

    Inventory

    $0.00
    NUVL annual inventory is $0.00

    Liabilities

    Total liabilities

    $71.96M
    NUVL annual total liabilities is $71.96 million

    Long term liabilities

    $17.94M
    NUVL annual total long term liabilities is $17.94 million

    Current liabilities

    $54.02M
    NUVL annual total current liabilities is $54.02 million

    Accounts payable

    $5.22M
    NUVL annual accounts payable is $5.22 million

    Debt

    Total debt

    $0.00
    NUVL annual total debt is $0.00

    Total debt 1-year change

    0%
    NUVL annual total debt has remained unchanged year-on-year

    Long term debt

    $0.00
    NUVL annual long term debt is $0.00

    Short term debt

    $0.00
    NUVL annual short term debt is $0.00

    Equity & Capital

    Shareholders equity

    $1.07B
    NUVL annual stockholders equity is $1.07 billion

    Book value

    $1.07B
    NUVL annual book value is $1.07 billion

    Retained earnings

    -$547.05M
    NUVL annual retained earnings is -$547.05 million

    Working capital

    $1.08B
    NUVL annual working capital is $1.08 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$185.06M
    NUVL annual cash flow from operations is -$185.06 million

    Cash from operations 1-year change

    -85.55%
    NUVL annual cash flow from operations is down -85.55% year-on-year

    Cash from investing

    -$573.51M
    NUVL annual cash flow from investing activities is -$573.51 million

    Cash from investing 1-year change

    -299.59%
    NUVL annual cash flow from investing activities is down -299.59% year-on-year

    Cash from financing

    $568.88M
    NUVL annual cash flow from financing activities is $568.88 million

    Cash from financing 1-year change

    +68.88%
    NUVL annual cash flow from financing activities is up +68.88% year-on-year

    CAPEX

    CAPEX

    $0.00
    NUVL annual capital expenditures is $0.00

    CAPEX 1-year change

    0%
    NUVL annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free cash flow

    -$185.06M
    NUVL annual free cash flow is -$185.06 million

    Free cash flow 1-year change

    -85.55%
    NUVL annual free cash flow is down -85.55% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    NUVL annual gross profit margin value is unknown

    Operating margin

    -
    NUVL annual operating profit margin value is unknown

    Net margin

    -
    NUVL annual net profit margin value is unknown

    ROA & ROE

    ROA

    -27.83%
    NUVL annual return on assets is -27.83%

    ROE

    -29.46%
    NUVL annual return on equity is -29.46%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    NUVL price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    NUVL price to earnings ratio is unknown

    PB Ratio

    PB ratio

    6.09
    NUVL price to book ratio is 6.09

    PB ratio Sector rank

    81.33%
    NUVL price to book ratio is higher than 81.33% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    NUVL price to sales ratio value is unknown

    PS ratio Sector rank

    -
    NUVL price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $4.72B
    NUVL enterprise value is $4.72 billion

    Enterprise value Sector rank

    87.56%
    NUVL enterprise value is higher than 87.56% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -13.04
    NUVL EV/EBITDA is -13.04

    EV/EBITDA Sector rank

    10.76%
    NUVL EV/EBITDA is higher than 10.76% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    20.96
    NUVL annual current ratio is 20.96

    Quick ratio

    20.96
    NUVL annual quick ratio is 20.96

    Leverage

    Debt to equity

    0.00
    NUVL annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    NUVL annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    NUVL piotroski f-score value is unknown

    Altman Z-Score

    47.40
    NUVL altman z-score is 47.40

    Analyst ratings

    Recent major analysts updates

    Sep 8, 25 Wedbush
    Outperform
    Sep 3, 25 Raymond James
    Outperform
    Aug 19, 25 Piper Sandler
    Overweight
    Jun 25, 25 Baird
    Outperform
    Jun 24, 25 Leerink Partners
    Outperform
    Jun 24, 25 HC Wainwright & Co.
    Buy
    Mar 14, 25 UBS
    Buy
    Mar 3, 25 HC Wainwright & Co.
    Buy
    Jan 17, 25 HC Wainwright & Co.
    Buy
    Dec 30, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with NUVL included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Stocks with high beta
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Nuvalent, Inc.?
    • Does Nuvalent, Inc. pay dividends?
    • What sector is Nuvalent, Inc. in?
    • What industry is Nuvalent, Inc. in?
    • What country is Nuvalent, Inc. based in?
    • When did Nuvalent, Inc. go public?
    • Is Nuvalent, Inc. in the S&P 500?
    • Is Nuvalent, Inc. in the NASDAQ 100?
    • Is Nuvalent, Inc. in the Dow Jones?
    • When was Nuvalent, Inc.'s last earnings report?
    • When does Nuvalent, Inc. report earnings?

    What is the ticker symbol for Nuvalent, Inc.?

    The ticker symbol for Nuvalent, Inc. is NASDAQ:NUVL

    Does Nuvalent, Inc. pay dividends?

    No, Nuvalent, Inc. does not pay dividends

    What sector is Nuvalent, Inc. in?

    Nuvalent, Inc. is in the Healthcare sector

    What industry is Nuvalent, Inc. in?

    Nuvalent, Inc. is in the Biotechnology industry

    What country is Nuvalent, Inc. based in?

    Nuvalent, Inc. is headquartered in United States

    When did Nuvalent, Inc. go public?

    Nuvalent, Inc.'s initial public offering (IPO) was on July 29, 2021

    Is Nuvalent, Inc. in the S&P 500?

    No, Nuvalent, Inc. is not included in the S&P 500 index

    Is Nuvalent, Inc. in the NASDAQ 100?

    No, Nuvalent, Inc. is not included in the NASDAQ 100 index

    Is Nuvalent, Inc. in the Dow Jones?

    No, Nuvalent, Inc. is not included in the Dow Jones index

    When was Nuvalent, Inc.'s last earnings report?

    Nuvalent, Inc.'s most recent earnings report was on May 8, 2025

    When does Nuvalent, Inc. report earnings?

    The next expected earnings date for Nuvalent, Inc. is November 10, 2025
    On this page